AGER and breast cancer: Of note, the stimulatory cross-talk between IR and RAGE was evidenced also in CAFs obtained from BC patients, suggesting that blocking RAGE represents an appealing strategy to halt oncogenic signals initiated by Ins also in the breast tumor microenvironment.